14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ABVE vs MAMA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
MAMA Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 10–0 Matrix Metrics)
MAMA Overall Winner
6-Pillar Tally: ABVE 2 – 4 MAMA
Matrix Metrics: ABVE 0 – 10 MAMA
As of Nov 16, 2026, Mama's Creations, Inc. (MAMA) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas MAMA carries 45.5/100 (HOLD) at $11.38 (43.3x Forward P/E, 5.2% operating margin).
Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile MAMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs MAMA. Trailing 12-month operating profitability (ABVE -23.2% vs MAMA 5.2%) and valuation multiples (ABVE N/M vs MAMA 43.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment20.4% of Rev ($60M)
90D Engineering Disclosures0 Published
MAMA Moat ProfileCyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $624.2M market capitalization and 5.2% operating margin.
OpEx & R&D Reinvestment19.1% of Rev ($40M)
90D Engineering Disclosures0 Published
Investor FAQ ABVE vs MAMA Key Questions & Quantitative Answers
As of Nov 16, 2026, Mama's Creations, Inc. (MAMA) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas MAMA carries 45.5/100 (HOLD) at $11.38 (43.3x Forward P/E, 5.2% operating margin). Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile MAMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MAMA leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with MAMA at +55.0% YoY revenue growth and +100.0% YoY earnings growth on $209M TTM revenue (24.3% gross margin, 5.2% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $209M for MAMA. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus 19.1% of Rev ($40M) (0 disclosures) for MAMA.
MAMA screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas MAMA trades at 43.3x Forward P/E, 82.8x Trailing P/E, N/M PEG, and 2.4x EV/Revenue (8.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus MAMA (7.5% ROE) capital efficiency.
In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, MAMA carries 60.6% implied volatility (33rd %ile, Balanced (25th–60th %ile)), a 6.53x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.80β · 53% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.